Abstract 4381: Preclinical studies of HEC211909, an orally bioavailable, high potent pan-KRAS inhibitor
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Haiwang Liu, Hongming Xie, Fuxing Tan, Ning Kang, Ming Li, Yingjun Zhang
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409629770